Atrial Flutter Clinical Trial
Official title:
EP Dynamics (EPD) Research First In Man Clinical Study
Demonstrate the safety, feasibility and usability of the EPD D700 system, for the first time
in humans, in subjects undergoing ablation for the treatment of atrial flutter.
Prospective, single-center, non-randomized, open label, single arm study. Ten consented
subjects who are scheduled to undergo ablation due to atrial flutter. All subjects will
undergo baseline assessment; intervention (standard fluoroscopy guided RF ablation procedure)
and post procedure follow up. All subjects will have a follow up visit within 24 hours post
procedure.
All procedures will be performed under standard fluoroscopic guidance for the treatment of
atrial flutter ablation procedure, and the D700 system will be used additionally to
demonstrate system safety, feasibility and usability.
The entire procedure will be conducted as customary, using standard and approved off-
the-shelf equipment (body surface electrodes, diagnostic and irrigated ablation catheters, RF
generator and recording system), in a completely clinically independent manner from the D700
system that will merely be a 'silent witness'. The operator will neither use nor rely on any
of the D700 system output for clinical decision making.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
| Terminated |
NCT02317029 -
Comparison of Oxygen Interventions and Defibrillator Efficiency
|
N/A | |
| Recruiting |
NCT01563848 -
Cryoablation in Patients With Atrial Flutter
|
Phase 2 | |
| Completed |
NCT01229254 -
Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter
|
Phase 2 | |
| Completed |
NCT00839657 -
Clarification of Optimal Anticoagulation Through Genetics
|
Phase 3 | |
| Completed |
NCT02065388 -
Pharmacogenetic Dosing of Warfarin
|
Phase 3 | |
| Completed |
NCT00232232 -
Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia
|
Phase 4 | |
| Completed |
NCT04884100 -
enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening
|
N/A | |
| Completed |
NCT05468281 -
RAFF5 Proposal: Improve the Quality and Safety of Patients Seen in the Emergency Department for Acute Atrial Fibrillation and Flutter
|
||
| Completed |
NCT03627143 -
Decreasing Hospital Admissions From the ED for AAFF
|
N/A | |
| Completed |
NCT02917538 -
A Randomized Trial of Contact Force in Atrial Flutter Ablation
|
N/A | |
| Enrolling by invitation |
NCT05903313 -
A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
|
||
| Recruiting |
NCT05755074 -
Ablation of Typical Right Atrial Flutter
|
N/A | |
| Recruiting |
NCT05883631 -
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
|
N/A | |
| Recruiting |
NCT03272620 -
Atrial Fibrillation at the Viennese University Emergency Department
|
N/A | |
| Completed |
NCT02810938 -
MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology
|
||
| Recruiting |
NCT02591875 -
Atrial Flutter Ablation in a Real World Population
|
N/A | |
| Completed |
NCT02268799 -
High Sensitivity Troponin T Levels Following DC Cardioversion for Atrial Fibrillation / Atrial Flutter
|
N/A | |
| Completed |
NCT01914497 -
Dipole Density Mapping of Typical Atrial Flutter
|
N/A | |
| Active, not recruiting |
NCT01976507 -
Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism
|
Phase 4 |